What are dopamine receptor agonists? These medicines constitute a class of drugs used to treat Parkinson’s disease (PD) symptoms that...see more
American Parkinson Disease Association Releases Symptom Tracker Mobile App With Expanded Features
The American Parkinson Disease Association (APDA) launches today a new and improved APDA Symptom Tracker App 2.0 – a...see more
La Asociación Americana de Enfermedad de Parkinson lanza la App Diario de síntomas en con funciones ampliadas
The American Parkinson Disease Association (la Asociación Americana de Enfermedad de Parkinson o APDA ) lanza una aplicación nueva...see more
Archived Webinar: Psychiatric Manifestations of Parkinson’s Disease
ARCHIVED: Free Webinar Hosted by University at Albany Aired on: Thursday, July 20, 2017 Watch Here University at Albany...see more
World Parkinson Congress 2016
2016 World Parkinson Congress Leadership Forum Before the 4th World Parkinson Congress officially kicked-off in Portland, Oregon nearly 200...see more
APDA Funded Researcher Published in Journal of Neuroscience – July 2016
APDA funded researcher published in Journal of Neuroscience – July 2016 APDA funded research demonstrates that alpha-synuclein inclusion formation...see more
ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin) is now available
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis is now available...see more
FDA Approves ACADIA Pharmaceuticals’ NUPLAZID™ (pimavanserin)
The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with...see more
Gene Therapy Prevents Parkinson’s Disease in Animal Model, Says Pitt Study
PITTSBURGH, June 15, 2015 – Gene therapy to...see more
APDA Launches Parkinson’s Awareness Training for First Responders
Unique symptoms of Parkinson’s can be mishandled and misunderstood in emergency situations. This new web-based program will educate police,...see more